Another drugmaker is recalling a medication used to treat high blood pressure and heart failure over concerns that tablets could be contaminated with a cancer-causing agent. Drug maker Aurobindo ...
The new year brings a new blood pressure medication recall. This time Aurobindo Pharma USA has recalled 80 lots of its Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets USP and Valsartan ...
Valsartan is used for the treatment of hypertension (high blood pressure) and for the treatment of heart failure. It is also indicated as a treatment for left ventricular failure and left ventricular ...
The main purpose of the two open, non-comparative PMS studies reported here was to extend the knowledge base of the efficacy and tolerability of once-daily valsartan (trial 1) and the fixed ...
Aurobindo Pharma USA, Inc. is recalling80 lots of Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets USP due totrace amounts of an unexpected impurity. This impurity ...
Concomitant therapy with the following medications was prohibited: other ARBs, angiotensin-converting enzyme (ACE) inhibitors, β-adrenergic antagonists, calcium-channel blockers, any other ...
The new year brings a new blood pressure medication recall. This time Aurobindo Pharma USA has recalled 80 lots of its Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets USP and Valsartan ...
Another drugmaker is recalling a medication used to treat high blood pressure and heart failure over concerns that tablets could be contaminated with a cancer-causing agent. Drug maker Aurobindo ...
General practitioners throughout Germany were invited to participate in two open-label, noncomparative PMS studies, performed in accordance with the guidelines of German Drug Law (AMG). The reporting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback